Sustainable trout feeds match conventional diets in new study
CURRENT BRIEF VERSION: Rainbow trout may be able to keep growing well on more sustainable aquafeeds that rely less on conventional fishmeal and fish oil. In a recent Animals study, researchers tested four extruded diets, including a conventional control and three “eco-efficient” formulations built with insect meal, algae-derived omega-3s, selected plant proteins, single-cell ingredients, and aquaculture by-products. The team reported that growth, body composition, nutrient retention, and flesh quality stayed comparable to the traditional feed, suggesting these alternative formulations can meet practical performance standards in trout production. Similar recent trout work has also found that insect-based substitutions can preserve growth and fillet quality in low-fishmeal diets, and related work in juvenile yellowtail found that replacing up to 35% of fishmeal protein with shark by-product-based composite protein mixtures did not reduce growth or survival over six weeks, although some EPA and DHA levels were lower in one by-product formulation. Together, the studies reinforce the broader direction of travel in aquafeed R&D. (mdpi.com)
Why it matters: For veterinary professionals working in aquaculture, the finding adds to evidence that lower-dependency feeds can be used without obvious trade-offs in fish performance or product quality, at least under controlled trial conditions. That matters because feed remains a major sustainability and cost pressure point in intensive aquaculture, and interest in insect meal, algae, and by-product proteins is being driven by both environmental concerns and volatility in conventional fishmeal markets. The yellowtail data also add a useful reminder that by-product-based replacements may support growth while still shifting fatty acid profiles, so formulation details matter. Industry tracking has shown novel ingredients such as insect meal, algae, and single-cell proteins are moving from pilot use into measurable commercial adoption, even if volumes are still small relative to standard ingredients. (mdpi.com)
What to watch: The next question is whether these formulations can hold up at commercial scale on cost, ingredient availability, regulatory fit, fatty acid quality, and longer-term fish health outcomes. (mdpi.com)